Oral sulfasalazine as a clinical BCRP probe substrate: Pharmacokinetic effects of genetic variation (C421A) and pantoprazole coadministration
10.1002/jps.21860
Saved in:
Main Authors: | Adkison, K.K., Vaidya, S.S., Mehta, A.A., Lee, D.Y., Polli, J.W., Humphreys, J.E., Koo, S.H., Li, L., Lee, E.J.D., Gross, A.S., Lou, Y. |
---|---|
Other Authors: | PHARMACOLOGY |
Format: | Article |
Published: |
2011
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/27290 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Oral sulfasalazine as a clinical BCRP probe substrate: Pharmacokinetic effects of genetic variation (C421A) and pantoprazole coadministration
by: Adkison, K.K., et al.
Published: (2016) -
The ABCG2 C421A polymorphism does not affect oral nitrofurantoin pharmacokinetics in healthy Chinese male subjects
by: Adkison, K.K., et al.
Published: (2011) -
Clinical pharmacology and pharmacogenetics of gemcitabine
by: Wong, A., et al.
Published: (2014) -
POPULATION SOURCED DISCOVERY OF GENETIC VARIANTS IN STATIN METABOLISM
by: YEE WEI LOONG SHERMAN
Published: (2020) -
PHARMACODYNAMICS, PHARMACOKINETICS AND PHARMACOGENETICS OF DOXORUBICIN IN SINGAPOREAN BREAST CANCER PATIENTS
by: FAN LU
Published: (2011)